Comparative study of Resistin and Glucose levels in COVID-19 patients
Keywords:
adipokine, COVID-19, diabetes mellitus, insulin resistance, resistinAbstract
Since the end of 2019, coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 has spread worldwide, it causes risks to public health. Adipokines perform a hormonal function and the most important adipokines that have received research interest are resistin, which is an important link between insulin resistance, and diabetes. This study aimed to estimate the level of Resistin and level of glucose and their relationship to diabetes in Covid-19 patients. The study was conducted on 65 patients with covid-19 and 23 healthy individuals in a control group, Resistin was assessed by the ELISA technique, it was resistin levels in male and female Covid-19 patients high(737.5714±103.44982, 638.5000±85.20096 respectively pg\ml) when compared to healthy males and females (363.7692±26.83405, 394.0000± 30.59412 respectively pg\ml).An elevated glucose level was observed in male and female patients (122.2000±9.703, 145.6667±11.55 mg/dl respectively)when compared to healthy males and females (90.8462±6.346, 102.3000±7.701 mg /dl respectively), This research found a high level of Resistin in Covid-19 patients.Therefore, it can be used as an important indicator to signify the complications of COVID-19 disease as well as for diagnosis, this hormone may have a relationship in causing new diabetes after infection Covid-19.
Downloads
References
Akbarov, A. N., & Xabilov, D. N. U. (2021). The condition of the oral cavity in patients who have had a viral infection COVID-19. International Journal of Health & Medical Sciences, 4(4), 381-383. https://doi.org/10.21744/ijhms.v4n4.1796
Al-Harithy, Rowyda N., and Shareefa Al-Ghamdi. 2005. “Serum Resistin, Adiposity and Insulin Resistance in Saudi Women with Type 2 Diabetes Mellitus.” Annals of Saudi Medicine 25(4):283–87.
Amato, Marco C., Giuseppe Pizzolanti, Vittoria Torregrossa, Gabriella Misiano, Salvatore Milano, and Carla Giordano. 2014. “Visceral Adiposity Index (VAI) Is Predictive of an Altered Adipokine Profile in Patients with Type 2 Diabetes.” PLoS One 9(3):e91969.
Darif, Dounia, Ikram Hammi, Ayyoub Kihel, Imane El Idrissi Saik, Fadila Guessous, and Khadija Akarid. 2021. “The Pro-Inflammatory Cytokines in COVID-19 Pathogenesis: What Goes Wrong?” Microbial Pathogenesis 153:104799.
Dasari, Ramya, and Vandana Raghunath. 2018. “Obesity and Type II Diabetes Mellitus: Is Resistin the Link?” Journal of Diabetes and Endocrine Practice 1(1):1.
Davids, Saarah Fatoma Gadija, Tandi Edith Matsha, Nasheeta Peer, Rajiv Timothy Erasmus, and Andre Pascal Kengne. 2020. “The 7-Year Change in the Prevalence of Insulin Resistance, Inflammatory Biomarkers, and Their Determinants in an Urban South African Population.” Journal of Diabetes Research 2020.
Dutta, Sulagna, Pallav Sengupta, Ravindran Jegasothy, and Roland Akhigbe. 2021. “Resistin and Visfatin:‘Connecting Threads’ of Immunity, Energy Modulations and Male Reproduction.” Chemical Biology Letters 8(4):192–201.
Ebihara, Takeshi, Hisatake Matsumoto, Tsunehiro Matsubara, Hiroshi Matsuura, Tomoya Hirose, Kentaro Shimizu, Hiroshi Ogura, Sujin Kang, Toshio Tanaka, and Takeshi Shimazu. 2021. “Adipocytokine Profile Reveals Resistin Forming a Prognostic-Related Cytokine Network in the Acute Phase of Sepsis.” Shock: Injury, Inflammation, and Sepsis: Laboratory and Clinical Approaches 56(5):718–26.
Ebihara, Takeshi, Hisatake Matsumoto, Tsunehiro Matsubara, Yuki Togami, Shunichiro Nakao, Hiroshi Matsuura, Takashi Kojima, Fuminori Sugihara, Daisuke Okuzaki, and Haruhiko Hirata. 2021. “Resistin Forms A Network With Inflammatory Cytokines And Endothelial Damage Markers And Provides Prognostic And Therapeutic Information For COVID-19.”
Edler, Carolin, Ann Sophie Schröder, Martin Aepfelbacher, Antonia Fitzek, Axel Heinemann, Fabian Heinrich, Anke Klein, Felicia Langenwalder, Marc Lütgehetmann, and Kira Meißner. 2020. “Dying with SARS-CoV-2 Infection—an Autopsy Study of the First Consecutive 80 Cases in Hamburg, Germany.” International Journal of Legal Medicine 134(4):1275–84.
Govender, Nalini, Olive P. Khaliq, Jagidesa Moodley, and Thajasvarie Naicker. 2021. “Insulin Resistance in COVID-19 and Diabetes.” Primary Care Diabetes 15(4):629–34.
Gual, Philippe, Teresa Gonzalez, Thierry Grémeaux, Romain Barres, Yannick Le Marchand-Brustel, and Jean-François Tanti. 2003. “Hyperosmotic Stress Inhibits Insulin Receptor Substrate-1 Function by Distinct Mechanisms in 3T3-L1 Adipocytes.” Journal of Biological Chemistry 278(29):26550–57.
Guan, Wei-jie, Zheng-yi Ni, Yu Hu, Wen-hua Liang, Chun-quan Ou, Jian-xing He, Lei Liu, Hong Shan, Chun-liang Lei, and David S. C. Hui. 2020. “Clinical Characteristics of Coronavirus Disease 2019 in China.” New England Journal of Medicine 382(18):1708–20.
Hamming, Inge, Wim Timens, M. L. C. Bulthuis, A. T. Lely, G. J. van Navis, and Harry van Goor. 2004. “Tissue Distribution of ACE2 Protein, the Functional Receptor for SARS Coronavirus. A First Step in Understanding SARS Pathogenesis.” The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland 203(2):631–37.
Hidalgo Filho, Cassio Murilo Trovo, Denise Silvia Mattioli Dalessandro Adamo, Camila Mendonça Lopes, and Eloísa Moreira Martin. 2021. “Thrombotic Thrombocytopenic Purpura Associated with COVID-19 in a Pediatric Patient: Case Report.” Hematology, Transfusion and Cell Therapy 43:349–52.
Hill, Michael A., Christos Mantzoros, and James R. Sowers. 2020. “Commentary: COVID-19 in Patients with Diabetes.” Metabolism 107:154217.
Huang, Chaolin, Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu, Li Zhang, Guohui Fan, Jiuyang Xu, and Xiaoying Gu. 2020. “Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China.” The Lancet 395(10223):497–506.
Hung, Amos C., Yen-Yun Wang, Kun-Tsung Lee, Hung-Hsing Chiang, Yuk-Kwan Chen, Je-Kang Du, Chun-Ming Chen, Michael Yuanchien Chen, Kwei-Jing Chen, and Stephen Chu-Sung Hu. 2021. “Reduced Tissue and Serum Resistin Expression as a Clinical Marker for Esophageal Squamous Cell Carcinoma.” Oncology Letters 22(5):1–8.
Jamaluddin, Md S., Sarah M. Weakley, Qizhi Yao, and Changyi Chen. 2012. “Resistin: Functional Roles and Therapeutic Considerations for Cardiovascular Disease.” British Journal of Pharmacology 165(3):622–32.
Jumli, Mimie Noratiqah, and Muhammad Ilyas Nadeem. 2021. “The Mechanistic and Pathophysiological Role of Adiponectin and Resistin Towards Regulation of Food Intake and Appetite in Cardiovascular Associated Risk Factor of Metabolic Syndrome.” in Type 2 Diabetes. IntechOpen.
Larroumet, Alice, Marion Camoin, Ninon Foussard, Laure Alexandre, Samir Mesli, Isabelle Redonnet, Laurence Baillet-Blanco, Vincent Rigalleau, and Kamel Mohammedi. 2020. “Euglycemic Ketoacidosis Induced by Therapeutic Fasting in a Non-Diabetic Patient.” Nutrition 72:110668.
Makrilakis, Konstantinos. 2019. “The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect.” International Journal of Environmental Research and Public Health 16(15):2720.
Malavazos, Alexis Elias, Massimiliano Marco Corsi Romanelli, Francesco Bandera, and Gianluca Iacobellis. 2020. “Targeting the Adipose Tissue in COVID‐19.” Obesity (Silver Spring, Md.).
Martin-Villares, Cristina, Carmen Perez Molina-Ramirez, Margarita Bartolome-Benito, and Manuel Bernal-Sprekelsen. 2021. “Outcome of 1890 Tracheostomies for Critical COVID-19 Patients: A National Cohort Study in Spain.” European Archives of Oto-Rhino-Laryngology 278(5):1605–12.
Musovic, Saliha, Man Mohan Shrestha, Ali M. Komai, and Charlotta S. Olofsson. 2021. “Resistin Is Co-Secreted with Adiponectin in White Mouse Adipocytes.” Biochemical and Biophysical Research Communications 534:707–13.
of the International, Coronaviridae Study Group. 2020. “The Species Severe Acute Respiratory Syndrome-Related Coronavirus: Classifying 2019-NCoV and Naming It SARS-CoV-2.” Nature Microbiology 5(4):536.
Page, Melissa M., and James D. Johnson. 2018. “Mild Suppression of Hyperinsulinemia to Treat Obesity and Insulin Resistance.” Trends in Endocrinology & Metabolism 29(6):389–99.
Parafiniuk, Klaudia, Wiktoria Skiba, Anna Pawłowska, Dorota Suszczyk, Aleksandra Maciejczyk, and Iwona Wertel. 2022. “The Role of the Adipokine Resistin in the Pathogenesis and Progression of Epithelial Ovarian Cancer.” Biomedicines 10(4):920.
Perpiñan, Carles, Laia Bertran, Ximena Terra, Carmen Aguilar, Jessica Binetti, Miguel Lopez-Dupla, Anna Rull, Laia Reverté, Elena Yeregui, and Frederic Gómez-Bertomeu. 2022. “Resistin and IL-15 as Predictors of Invasive Mechanical Ventilation in COVID-19 Pneumonia Irrespective of the Presence of Obesity and Metabolic Syndrome.” Journal of Personalized Medicine 12(3):391.
Raimundoa, Priscila Romano, Vinícius Peixoto Rodrigues, Maycon Tavares Emílio-Silvaa, Gabriela Buenoa, Victoria Gabrielle Gomesa, Lúcia Regina Machado da Rocha, and Clélia Akiko Hiruma-Lima. 2021. “Is Citral´ s Anti-Inflammatory Action Capable of Changing the Hypothalamic Inflammation in Obese Mice?”
Rajpal, Aman, Leili Rahimi, and Faramarz Ismail-Beigi. 2021. “Diabetes Mellitus and COVID-19: A Short Communication.” Medical Reports andCase Studies 0–2.
Rubino, Francesco, Stephanie A. Amiel, Paul Zimmet, George Alberti, Stefan Bornstein, Robert H. Eckel, Geltrude Mingrone, Bernhard Boehm, Mark E. Cooper, and Zhonglin Chai. 2020. “New-Onset Diabetes in Covid-19.” New England Journal of Medicine 383(8):789–90.
Santos, Izabelle Barcellos, Graziele Freitas de Bem, Cristiane Aguiar da Costa, Lenize Costa Reis Marins de Carvalho, Amanda Faria de Medeiros, Dafne Lopes Beserra Silva, Matheus Henrique Romão, Ricardo de Andrade Soares, Dayane Teixeira Ognibene, and Roberto Soares de Moura. 2020. “Açaí Seed Extract Prevents the Renin-Angiotensin System Activation, Oxidative Stress and Inflammation in White Adipose Tissue of High-Fat Diet–Fed Mice.” Nutrition Research 79:35–49.
Steel, Robert George Douglas, and James Hiram Torrie. 1960. “Principles and Procedures of Statistics.” Principles and Procedures of Statistics.
Su, Kai-zhen, Yan-run Li, Di Zhang, Jun-hua Yuan, Cai-shun Zhang, Yuan Liu, Li-min Song, Qian Lin, Man-wen Li, and Jing Dong. 2019. “Relation of Circulating Resistin to Insulin Resistance in Type 2 Diabetes and Obesity: A Systematic Review and Meta-Analysis.” Frontiers in Physiology 1399.
Taouis, Mohammed, and Yacir Benomar. 2021. “Is Resistin the Master Link between Inflammation and Inflammation-Related Chronic Diseases?” Molecular and Cellular Endocrinology 533:111341.
Widana, I.K., Sumetri, N.W., Sutapa, I.K., Suryasa, W. (2021). Anthropometric measures for better cardiovascular and musculoskeletal health. Computer Applications in Engineering Education, 29(3), 550–561. https://doi.org/10.1002/cae.22202
Wilson, Clare. 2022. “Is Covid-19 Causing Diabetes?”
Yang, Jin-Kui, Shan-Shan Lin, Xiu-Juan Ji, and Li-Min Guo. 2010. “Binding of SARS Coronavirus to Its Receptor Damages Islets and Causes Acute Diabetes.” Acta Diabetologica 47(3):193–99.
Zhang, Jiancheng, Bing Xie, and Kenji Hashimoto. 2020. “Current Status of Potential Therapeutic Candidates for the COVID-19 Crisis.” Brain, Behavior, and Immunity 87:59–73.
Ziegler, Carly G. K., Samuel J. Allon, Sarah K. Nyquist, Ian M. Mbano, Vincent N. Miao, Constantine N. Tzouanas, Yuming Cao, Ashraf S. Yousif, Julia Bals, and Blake M. Hauser. 2020. “SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.” Cell 181(5):1016–35.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.